Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury - PubMed (original) (raw)

Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury

Kenichi Imahashi et al. Circ Res. 2004.

Abstract

The antiapoptotic protein Bcl-2 is targeted to the mitochondria, but it is uncertain whether Bcl-2 affects only myocyte survival after ischemia, or whether it also affects metabolic functions of mitochondria during ischemia. Hearts from mice overexpressing human Bcl-2 and from their wild-type littermates (WT) were subjected to 24 minutes of global ischemia followed by reperfusion. During ischemia, the decrease in pH(i) and the initial rate of decline in ATP were significantly reduced in Bcl-2 hearts compared with WT hearts (P<0.05). The reduced acidification during ischemia was dependent on the activity of mitochondrial F1F0-ATPase. In the presence of oligomycin (Oligo), an F1F0-ATPase inhibitor, the decrease in pH(i) was attenuated in WT hearts, but in Bcl-2 hearts, Oligo had no additional effect on pH(i) during ischemia. Likewise, addition of Oligo to WT hearts slowed the rate of decline in ATP during ischemia to a level similar to that observed in Bcl-2 hearts, but addition of Oligo had no significant effect on the rate of decline in ATP in Bcl-2 hearts during ischemia. These data are consistent with Bcl-2-mediated inhibition of consumption of glycolytic ATP. Furthermore, mitochondria from Bcl-2 hearts have a reduced rate of consumption of ATP on uncoupler addition. This could be accomplished by limiting ATP entry into the mitochondria through the voltage-dependent anion channel, and/or the adenine nucleotide transporter, or by direct inhibition of the F1F0-ATPase. Immunoprecipitation showed greater interaction between Bcl-2 and voltage-dependent anion channel during ischemia. These data indicate that Bcl-2 modulation of metabolism contributes to cardioprotection.

PubMed Disclaimer

Cited by

Sauchinone augments cardiomyocyte viability by enhancing autophagy proteins -PI3K, ERK(1/2), AMPK and Beclin-1 during early ischemia-reperfusion injury in vitro.
Thapalia BA, Zhou Z, Lin X. Thapalia BA, et al. Am J Transl Res. 2016 Jul 15;8(7):3251-65. eCollection 2016. Am J Transl Res. 2016. PMID: 27508047 Free PMC article.
Glutaredoxin regulates apoptosis in cardiomyocytes via NFkappaB targets Bcl-2 and Bcl-xL: implications for cardiac aging.
Gallogly MM, Shelton MD, Qanungo S, Pai HV, Starke DW, Hoppel CL, Lesnefsky EJ, Mieyal JJ. Gallogly MM, et al. Antioxid Redox Signal. 2010 Jun 15;12(12):1339-53. doi: 10.1089/ars.2009.2791. Antioxid Redox Signal. 2010. PMID: 19938943 Free PMC article.
Overcoming an energy crisis?: an adaptive role of glycogen synthase kinase-3 inhibition in ischemia/reperfusion.
Zhai P, Sadoshima J. Zhai P, et al. Circ Res. 2008 Oct 24;103(9):910-3. doi: 10.1161/01.RES.0000338259.37472.b6. Circ Res. 2008. PMID: 18948628 Free PMC article. No abstract available.
Vagal nerve stimulation protects cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model.
Lu X, Costantini T, Lopez NE, Wolf PL, Hageny AM, Putnam J, Eliceiri B, Coimbra R. Lu X, et al. J Cell Mol Med. 2013 May;17(5):664-71. doi: 10.1111/jcmm.12049. Epub 2013 Apr 12. J Cell Mol Med. 2013. PMID: 23577721 Free PMC article.
MicroRNA-181c targets Bcl-2 and regulates mitochondrial morphology in myocardial cells.
Wang H, Li J, Chi H, Zhang F, Zhu X, Cai J, Yang X. Wang H, et al. J Cell Mol Med. 2015 Sep;19(9):2084-97. doi: 10.1111/jcmm.12563. Epub 2015 Apr 20. J Cell Mol Med. 2015. PMID: 25898913 Free PMC article.

Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury - PubMed (original) (raw)